Defence PSU boom! Garden Reach Shipbuilders & Engineers stock rockets 20%-what's driving the surge?

Mumbai/IBNS, April 1 -- The share prices of Garden Reach Ship Builders & Engineers Ltd. (GRSE) soared as much as 20% on Wednesday after it reported a strong growth momentum for FY26, media reports sai... Read More

BSE SME Tipco Engineering India lists with a whisper, not a roar

Mumbai, April 1 -- The scrip listed at Rs 89.25, a 0.28% premium to the issue price. The stock is currently hovering near its listing price. The stock touched a high of Rs 90 and a low of Rs 84.81, wi... Read More

NTPC Green Energy rises after arm inks Green Ammonia supply pact with SECI

Mumbai, April 1 -- The agreement involves the supply of 70,000 metric tons per annum (MTPA) of green ammonia under the SIGHT scheme of the National Green Hydrogen Mission, Government of India. Under ... Read More

Srichakra Polyplast backer Circulate Capital marks first close of second Asia fund

New Delhi, April 1 -- Singapore-headquartered private equity firm Circulate Capital said Wednesday it has marked the first close of its second Asia-focused fund after securing $220 million (around Rs ... Read More

LPG and aviation fuel prices rise sharply amid global energy disruptions

Mumbai, April 1 -- Amid ongoing global energy supply challenges, state-run oil marketing companies in India have increased prices of commercial LPG and aviation turbine fuel (ATF), leading to a sharp ... Read More

UAE Suspends All Visa Categories for Iranians Over Security Concerns

Afghanistan, April 1 -- The United Arab Emirates has suspended all visa categories for Iranian nationals, citing immediate travel and security measures amid heightened regional tensions. Flydubai sai... Read More

Singapore Clinical Trial: ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Bevacizumab in Combination with Chemotherapy in Participants with Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'ROSETTA CRC-203: A Blinded, Randomized Phase 2/3 Study of Pumitamig in Combination with Chemothera... Read More

Singapore Clinical Trial: A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety and Efficacy of L606 (Treprostinil Liposome Inhalation Suspension) in Participants with Pulmonary Hypertension Associated with Interstitial Lung Disease (WHO Group 3)

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safet... Read More

Singapore Clinical Trial: A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) Monotherapy versus Physician’s Choice of Chemotherapy in Participants with B7-H4-Selected Advanced/Metastatic Endometrial Cancer Who Progressed On or After Platinum-Based Chemotherapy and Anti-PD-1/Anti-PD-L1 Therapy (BLUESTAR-Endometrial01)

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Randomized, Open-Label, Multicenter, Global Study of Puxitatug Samrotecan (AZD8205) M... Read More

Singapore Clinical Trial: DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig in combination with atezolizumab, carboplatin, and etoposide vs. atezolizumab, carboplatin, and etoposide as first-line treatment in patients with extensive-stage small cell lung cancer

Singapore, April 1 -- The Health Sciences Authority received information related to the study titled 'DAREON®-Lung 1: A Phase III multi-center, open-label, randomised trial of intravenous obrixtamig i... Read More

• ««
• «
• 5407
• 5408
• 5409
• 5410
• 5411
• 5412
• 5413
• 5414
• 5415
• 5416
• »
• »»